Spark Therapeutics CEO Jeffrey Marrazzo's 2018 pay falls 27% to $3.6M
Spark Therapeutics reports 2018 executive compensation
By ExecPay News
Published: July 22, 2019
Spark Therapeutics reported fiscal year 2018 executive compensation information on July 22, 2019.
In 2018, five executives at Spark Therapeutics received on average a compensation package of $2.7M, a 11% increase compared to previous year.
Average pay of disclosed executives at Spark Therapeutics
Jeffrey D. Marrazzo, Chief Executive Officer, received $3.6M in total, which decreased by 27% compared to 2017. 50% of Marrazzo's compensation, or $1.8M, was in option awards. Marrazzo also received $394K in non-equity incentive plan, $596K in salary, $758K in stock awards, as well as $39K in other compensation.
For fiscal year 2018, the median employee pay was $182,200 at Spark Therapeutics. Therefore, the ratio of Jeffrey D. Marrazzo's pay to the median employee pay was 20 to one.
John Furey, Chief Operating Officer, received a compensation package of $2.8M, which increased by 279% compared to previous year. 43% of the compensation package, or $1.2M, was in option awards.
Daniel R. Faga, Chief Business Officer, earned $2.5M in 2018, a 15% increase compared to previous year.
Katherine A. High, President and Head of Research and Development, received $2.3M in 2018, which decreases by 8% compared to 2017.
Stephen W. Webster, Chief Financial Officer, earned $2.1M in 2018, a 1% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on July 22, 2019.